管理我的频道

Hayman Capital's Bass: J&J vaccine halt isn't an event for the market

U.S. stock futures dropped in a sudden move after the U.S. Food and Drug Administration said it’s recommending a pause in the Johnson & Johnson Covid vaccine after reported cases of blood clotting. Kyle Bass, Hayman Capital Management chief investment officer, offers his reaction to the news and how he thinks it will affect the market.

原文连结六度声明DMCA 政策

相关新闻

猜你喜欢

焦点新闻

全部留言 0